Nuclear Medicine and Molecular Imaging Update
hosted byAmerican Seminar Institute (ASI)Nuclear Medicine and Molecular Imaging Update is organized by American Seminar Institute (ASI).
Release date: August 20, 2022
Expiration date: August 19, 2025
Topics:
Session 1: Impact and Future of Nuclear Medicine
0th Anniversary of the MECSNMMI and the Next 50 years and Unparalleled and Revolutionary Impact of PET Imaging on Research and Day to Day Practice of Medicine.
Session 2: Nuclear Medicine and the Neuroendocrine System
Understanding Neuroendocrine Tumors and the Role of Copper Cu 64 Dotatate; Partners in Crime: Nuclear Medicine and Surgery Defeating Endocrinopathies Through Teamwork; and RAI Resistant Thyroid Cancer: What is Next?
Session 3: Caridiac and Pumonary Applications of Nuclear Medicine and PET
Diagnosis and Treatment of Cardiac Sarcoidosis; Role of PET/CT in Management of Lung Cancr; and Lack of Association Between Atrial FTG Uptake and Atrial Fibrillation in Patients With PET/CT.
Session 4: Neuro
Machine Learning in the Imaging of Dementia and Brain FDG-PET Findings in COVID-19.
Session 5: Pediatrics, Prostate and Rheumatology
PSMA PET/CT Imaging in Prostate Cancer; Nuclear Medicine and Rheumatology; and Cases in Pediatric Nuclear Medicine.
Session 6: General Imaging Applications
Benefits of SPECT-CT and Quality and Safety in Radiology.
Course Objectives:
Following this enduring material, the participants will be able to:
• Describe FDG PET-CT’s impact on the practice of medicine.
• Explain the value of molecular profiling in the treatment of iodine resistant thyroid cancer.
• Discuss nuclear medicine’s involvement in the diagnostic evaluation, treatment and surveillance of cardiac sarcoidosis.
• Describe the synergy, benefits and limitations of artificial intelligence in nuclear medicine.
• Explain PSMA PET-CT’s enhancements to the reporting and therapy of prostate cancer.
• Discuss the potential of whole body PET on imaging and interpretation.